
    
      Magnetic Resonance Imaging (MRI) is currently the method of choice for non-invasive diagnosis
      of primary liver tumors. However, differentiation of hepatocellular carcinoma (HCC) from
      adenoma and focal nodular hyperplasia (FNH) remains challenging, particularly in
      non-cirrhotic patients.
    
  